In recent years, a large number of studies have reported a connection between the cGAS-STING signaling pathway and anti-tumor immunity, cancer progression, the tumor microenvironment, and pharmacological strategies for cancer treatment (Jiang et al., 2020; Kwon and Bakhoum, 2020; Wang, 2020). This evidence concerns the gene STING1 and cancer.